If you had a life-threatening disease and were offered a choice of treatments, would you opt for a one-time cure or for weekly treatments for the rest of your life? The answer for most people is unsurprising: a cure. Cures eliminate the inconvenience of ongoing treatment, decrease caregiver burden, and reduce patient anxiety.
Although we want cures, how do payers, policy makers, and pharmaceutical manufacturers place a price on them?
J Clin Pathways.
Is trying to use the tools of economics to values cures useful, or–as Winston Wong writes–is cost-effectiveness modeling “not sensitive nor sophisticated enough” for curative therapies?
Read my full response– titled “How to Value Curative Therapies“–which was published in the Journal of Clinical Pathways today.
How to Value Curative Therapies posted first on http://drugsscreeningpage.blogspot.com/
No comments:
Post a Comment